UoH, Mumbai firm secure patent for rapid molecular testing tech
The story in brief
The University of Hyderabad and Mumbai-based miBiome Therapeutics LLP have been granted a patent for rapid molecular testing technology. The invention, born from a collaborative research initiative during the Covid-19 pandemic, uses next-generation sequencing to process multiple DNA/RNA samples. Each sample is tagged with a unique molecular barcode, enabling individual identification even when pooled for testing.